| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ALX4-STK33-20-RERE | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-REOR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-REGO | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-REGR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-REAQ | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-ORRE | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-OROR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-ORGO | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-ORGR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-ORAQ | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-GORE | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-GOOR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-GOGO | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-GOGR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-GOAQ | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-GRRE | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-GROR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-GRGO | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-GRGR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-GRAQ | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-AQRE | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-AQOR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-AQGO | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-AQGR | 20 (40 μL) | 200 μL |
|
Request Pricing |
| ALX4-STK33-20-AQAQ | 20 (40 μL) | 200 μL |
|
Request Pricing |
This gene encodes a paired-like homeodomain transcription factor expressed in the mesenchyme of developing bones, limbs, hair, teeth, and mammary tissue. Mutations in this gene cause parietal foramina 2 (PFM2); an autosomal dominant disease characterized by deficient ossification of the parietal bones. Mutations in this gene also cause a form of frontonasal dysplasia with alopecia and hypogonadism; suggesting a role for this gene in craniofacial development, mesenchymal-epithelial communication, and hair follicle development. Deletion of a segment of chromosome 11 containing this gene, del(11)(p11p12), causes Potocki-Shaffer syndrome (PSS); a syndrome characterized by craniofacial anomalies, cognitive disability, multiple exostoses, and genital abnormalities in males. In mouse, this gene has been shown to use dual translation initiation sites located 16 codons apart. [provided by RefSeq, Oct 2009]
Gene Symbol : ALX4
Gene Name : ALX homeobox 4
Chromosome : CHR 11: 443,101,65-442,607,27
Locus : 11p11.2
Gene Symbol : STK33
Gene Name : Serine/threonine kinase 33
Chromosome : CHR 11: 859,428,8-833,502,8
Locus : 11p15.4
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Lorem Ipsum is simply dummy text of the printing and typesetting industry.